Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-24
DOI
10.3389/fonc.2019.00659
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer
- (2018) Kristian Hastoft Jensen et al. ACTA ONCOLOGICA
- Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment
- (2018) H. Picchi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti- Mycobacterium tuberculosis agents
- (2018) So Takata et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- The tuberculosis-associated immune reconstitution inflammatory syndrome
- (2018) Naomi F. Walker et al. Current Opinion in HIV and AIDS
- Re-activation of pulmonary tuberculosis during anti-programmed death-1 (PD-1) treatment
- (2018) C -C Tsai et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report
- (2018) Wan He et al. OncoTargets and Therapy
- Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti–PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma
- (2017) Yi-Chun Chu et al. Journal of Thoracic Oncology
- Supportive care for patients undergoing immunotherapy
- (2017) Bernardo Leon Rapoport et al. SUPPORTIVE CARE IN CANCER
- Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
- (2017) Liting Guo et al. Journal of Cancer
- Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma
- (2016) Joycelyn J. X. Lee et al. ACTA ONCOLOGICA
- MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage
- (2016) N T T Thuong et al. GENES AND IMMUNITY
- Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Lindsey Robert Baden et al. Journal of the National Comprehensive Cancer Network
- Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
- (2016) Thanyanan Reungwetwattana et al. Journal of Thoracic Oncology
- Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
- (2016) Kohei Fujita et al. Journal of Thoracic Oncology
- CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
- (2016) Shunsuke Sakai et al. PLoS Pathogens
- A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors
- (2015) T. W. Chen et al. ANNALS OF ONCOLOGY
- Smoking and Mortality — Beyond Established Causes
- (2015) Brian D. Carter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-γ Inhibits Nonopsonized Phagocytosis of Macrophages via an mTORC1-c/EBP� Pathway
- (2014) Zengfu Wang et al. Journal of Innate Immunity
- Opportunistic infections in patients treated with immunotherapy for cancer
- (2014) Chrisann Kyi et al. Journal for ImmunoTherapy of Cancer
- Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study
- (2013) S-C Kuo et al. BRITISH JOURNAL OF CANCER
- T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
- (2011) Sultan Tousif et al. PLoS One
- CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
- (2010) D. L. Barber et al. JOURNAL OF IMMUNOLOGY
- Tuberculosis and malignancy
- (2010) M.E. Falagas et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- MARCO, TLR2, and CD14 Are Required for Macrophage Cytokine Responses to Mycobacterial Trehalose Dimycolate and Mycobacterium tuberculosis
- (2009) Dawn M. E. Bowdish et al. PLoS Pathogens
- Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
- (2008) Keer Sun et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now